Known Group Inc. Logo

“Through our work at JESSCO, we quickly realized that there is vast opportunity within the cannabis, psychedelics and health industries. Known is uniquely positioned to offer the services that organizations need for success,” says Jess Moran, Founder of The Known Group Inc.

TORONTO (PRWEB)
November 19, 2021

Known Group Inc. (“Known” or the “Group”) is proud to announce the launch of a new public relations and communications agency that supports the cannabis, psychedelics, and health and wellness industries. Known is a rebranding and expansion initiative that will transform the JESSCO Agency, founded by Jess Moran, into a clear leader in the promotion and communication goals of emerging industries.

The Group combines more than 35 years of experience in public relations, marketing, communications, and technology translation, with deep knowledge of cannabis, psychedelics and health. Industry trailblazer Jess Moran, Founder of Known, is supported by a core team of experts and a vast network of advisors and friends.

Jess was recognized as a PR in Canada Top 40 under 40 and High! Magazine Canadian Cannabis Hero, and currently sits on the advisory board of O’Cannabiz, Breaking The Stigma (BTS), Medicinal My Way, Crossing All Bridges, Cannabis For Harm Reduction, and is the Volunteer Marketing Director for Athletes for CARE. As a proud Autism sister and mother, this fuels her passion for autism, neurodiversity, and special needs advocacy.

“Through our work at JESSCO, we quickly realized that there is vast opportunity within the cannabis, psychedelics and health industries. Our team of experts and advisors are uniquely positioned to offer the services that organizations need for success,” says Jess Moran, Founder of The Known Group Inc. “I couldn’t be more excited to take this step as an agency – with the backing of a proven track record, solid client roster, and seasoned advisors – providing a solid foundation for current and future growth.”

Roderick S. MacDonald, Senior Director of Communications, brings targeted expertise in the psychedelic industry along with extensive knowledge of cannabis, biochemistry, technology communication, investor relations, and reputation management.

The Known Advisory Board includes Ashleigh Brown, founder of SheCann and cannabis advocate, Jeannette Vandermarel, co-founder of one of the first licensed producers in Canada and holding board appointments across the industry, Dessy Pavlova, multiple co-founder in the cannabis and psychedelic industries, Amy Prentice, Director of PR and Communications at Ample Organics, and Christina Michael, founder of the Entourage Collective and other cannabis initiatives, among others with unique areas of expertise.

Known’s core service offering will include public relations, marketing, brand and business development, digital communications, advocacy and education; specializing in start-up and fast-growth environments in emerging private and public markets.

The Group has proudly serviced 30+ clients over two years (operating as JESSCO) including High Tide (NASDAQ:HITI), Canna Cabana, Dynaleo, Nuveev Wellness, Rapid Dose Therapeutics (CSE:DOSE), Elias Theodorou, Athletes for CARE, Greenway Greenhouse (CSE:GWAY), Kalvara Canada, Fritz’s Cannabis Company, Gallery Brands, Chef Jordan Wagman, The Telehealth Association of Canada, and The Health Depot.

About Known Group Inc.

Known Group Inc. is formed by a group of passionate cannabis and psychedelic industry advocates with over 25 years in communications and digital marketing experience with key connections spanning media, healthcare, technology, cannabis and psychedelics. Primary services include public relations, marketing, digital communications, and business development. Their clients are seen in Forbes, Canadian Press, Global, CTV, CBC, Healthline, The Globe & Mail, The National Post, High Times, The Fresh Toast, The Grow-Op, Mugglehead, Yahoo Finance, Huffington Post & more. We are Known for a passion for advocacy and education. More information is available on KnownGroup.ca and @knowngroupinc on all social media platforms.

Share article on social media or email:

WASHINGTON (PRWEB)
November 19, 2021

Today, the Dialysis Vascular Access Coalition (DVAC) announced that it fully supports the effort of the Congressional Tri-Caucus to demand that Congress act urgently to direct CMS not to move forward with the implementation of the clinical labor update and to stop 20% cuts to vascular access services. See the Congressional Tri-Caucus Letter here.

DVAC is urging Congress to take action before the CMS-directed cuts take effect in 2022 and to reform the PFS to protect patients and providers.

Dr. Gregg Miller, DVAC’s Health Policy Chair, said, “There is significant momentum to fix this by the end of the year due to the widespread negative impacts this CMS decision would have on patients and our entire health care delivery system. DVAC is grateful to the Congressional Tri-Caucus for leading the charge and bringing their voice to this fight for health equity and patient access. Congress must act to make sure that hundreds of thousands of Americans in need of dialysis treatment can get the best possible care without interruption.”

Each year, Vascular Access Centers treat more than half of a million cases in the United States in a safe, patient-preferred setting and the proposed cut of 20% will force many of these centers to close. In the 2017 PFS, CMS cut payments to a key vascular access code by 39%. Now these same providers are on the chopping block again for an additional 20% cut, even though data has shown that high-quality care is essential for vascular access.

Share article on social media or email:

Everest Group Names Access Healthcare a “Major Contender” in Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022

“We recognize that the future is digital. From our inception, we have been building technologies to deliver revenue cycle processes at a differentiated cost structure to our clients and ease the burden on our workforce,” says Vardhman Jain, Vice-Chairman, Access Healthcare.

DALLAS (PRWEB)
November 19, 2021

Access Healthcare, a leading provider of end-to-end healthcare revenue cycle and information technology services, announced that the company has been named a “Major Contender” in Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022.

Access Healthcare’s technology focus is evident in its completely automated delivery architecture, including workflow, knowledge management, client collaboration, employee training, performance, communication, and collaboration tools. Through COVID-19 lockdowns and the first ten months of the year, the company has demonstrated tremendous resilience and reinvented its people processes to support its healthcare clients through the unprecedented crisis.

Recently, Access Healthcare began offering echo, its proprietary robotic process automation and artificial intelligence platform with pre-built automation use cases for almost the entire revenue cycle chain.

“We recognize that the future is digital. From our inception, we have been building technologies to deliver revenue cycle processes at a differentiated cost structure to our clients and ease the burden on our workforce. In the first phase, we built enabling business process management technologies and took a giant leap forward with echo,” says Vardhman Jain, Vice-Chairman, Access Healthcare.

“The inclusion in the Everest PEAK Matrix® is a significant step forward for us. As a business process services provider, we have tried to solve some of the most pressing needs of revenue cycle operations – improving human productivity, applying insights from data to make impactful decisions, and achieving near 100% straight-through automation, where possible. While the revenue cycle poses a complex automation puzzle, the headway that we have made through echo positions us well for the future,” says Prabhakar Munuswamy, Vice President of Application Development.

“The revenue cycle industry is due for a digital transformation. Over the past five years, we have experimented with multiple technologies and frameworks to create echo. We have comprehensively tested it in our revenue cycle operations and have now taken it to our customers and partners resulting in transformational outcomes,” states Arvind Perumbala, Vice President of Business Development.

ABOUT ACCESS HEALTHCARE

Access Healthcare provides business process outsourcing, applications services, and robotic process automation tools to hospitals, health systems, providers, payers, and related service providers. The company operates from 19 global delivery centers in the US, India, and the Philippines. Their 18,000+ staff is committed to bringing revenue cycle excellence to clients by leveraging technology, emerging best practices, and global delivery. Based in Dallas, TX, the company supports over 300,000 healthcare providers through 70+ clients, serving 80+ specialties, processing over $70 billion of A/R annually, and ascribing medical codes to over 30 million charts annually.

With over 3,500 virtual bots in operation, Access Healthcare’s proprietary robotic process automation platform helps its clients improve efficiency. Access Healthcare is HITRUST, PCI DSS, SOC, ISO 27001, and ISO 9001 certified, providing the needed security, availability, and confidentiality of sensitive health information. Their people program, integrated processes, and proven track record of service delivery have earned Access Healthcare the “Leader” and “Star Performer” award by Everest Group’s Healthcare Provider BPO Peak Matrix. For more information, visit http://www.accesshealthcare.com

Share article on social media or email:

Biospectal OptiBP: The Optical Revolution in Blood Pressure Management

Biospectal is on the right track with its mission to democratize access to blood pressure monitoring and management globally via easy to access, easy to use, medical grade applications in consumer mobile devices.

LAUSANNE, Switzerland and SAN FRANCISCO (PRWEB)
November 19, 2021

Biospectal SA, the remote patient monitoring biosensing software company, today announced the Biospectal OptiBP™ smartphone blood pressure monitoring app and data platform has been named a winner in the Health category for Fast Company’s Next Big Things in Tech list, honoring the technology breakthroughs that promise to shape the future of their industries — from healthcare to agriculture to artificial intelligence and more. Biospectal OptiBP for Android launched in public beta in January 2021. Biospectal OptiBP for iOS is currently in alpha and is planned for public beta launch in the second half of 2021. View a short video of how Biospectal OptiBP works here.

Featured in the Winter 2021 print issue of Fast Company, the final list includes global giants, intrepid startups, research that is fresh from the labs and recognizes 65 technologies that are making waves. While not all of the products, services, and technological developments are on the market yet, they’re reaching key milestones. All submissions were judged based on their relevancy, ingenuity, and current and potential cultural and business impact.

“It’s an honor for us to be recognized not only for the positive impact we have made in the last 12 months, but also for the transformation OptiBP will drive for consumers, businesses, and society at large over the next five years and beyond,” said Biospectal CEO and co-founder, Eliott Jones. “Winning the Health category for The Next Big Things in Tech further validates that Biospectal is on the right track with its mission to democratize access to blood pressure monitoring and management globally via easy to access, easy to use, medical grade applications in consumer mobile devices.”

The World Health Organization estimates 1.3Bn people worldwide have hypertension. Dubbed the “silent killer,” only one in five people afflicted with hypertension have control over the condition. Democratizing blood pressure management at global scale enables population scale improvement in addressing the most prevalent chronic health condition globally. Biospectal’s OptiBP is a prime example of a broader transition to remote patient monitoring that moves the clinical process and capability out of the professional setting to the ‘point of patient,’ lowering cost and improving effectiveness.

Biospectal’s OptiBP app enables anyone with a smartphone to monitor their blood pressure easily and quickly — anytime, anywhere just by placing a fingertip on a smartphone camera lens. OptiBP records blood flow using a breakthrough optical signal processing algorithm to “see” the pulse and estimate blood pressure. The process takes 20 seconds – half the time of a typical blood pressure cuff. As a pure software solution rather than a wearable, anyone in the world with a smartphone can transform their device into a connected, smart, clinical-grade monitor in the time it takes to download and install an app. In addition to revolutionizing access and user experience, OptiBP connects users’ data effortlessly to their doctor, enabling insight and improved treatment regimens that achieve the ultimate goal of improving health, longevity and quality of life. In short, Biospectal OptiBP replaces the bulky, inconvenient, and antiquated traditional blood pressure cuff with the built in camera sensor and connected data capabilities of the phone people already carry with them every day.

Biospectal OptiBP has been validated by extensive independent, third-party research, with results confirming its clinical grade accuracy published in http:// Scientific Reports in Nature. Further clinical study results published in Blood Pressure Monitoring Journal confirmed Biospectal OptiBP app’s achievement of the ISO 81060-2 international standard for blood pressure measurement device accuracy. No other blood pressure monitoring and management solution on the market offers both the convenience of an app based approach and medical-grade accuracy of Biospectal OptiBP.

“Fast Company is thrilled to highlight cutting-edge technologies that are solving real-world problems in unexpected ways. From climate change and public health crises to machine learning and security, these technologies will certainly have a profound impact on the future, and we’re honored to bring attention to them today,” says Stephanie Mehta, editor-in-chief of Fast Company.

The Winter 2021/2022 issue of Fast Company is available online now and will hit newsstands on December 7. Click here to see the final list.

About Biospectal

Biospectal SA is the remote monitoring and biosensing software company focused on the worldwide democratization of clinical monitoring. We make it easy for hypertension patients and health-conscious consumers to take on hypertension, the ‘silent killer’ and #1 chronic health condition worldwide. Biospectal’s OptiBP™ smartphone application and data platform removes the traditional blood pressure cuff barrier and enables frequent and intelligent blood pressure tracking via a fingertip applied to a smartphone camera lens. By optically measuring blood flow through the skin, our proprietary algorithm turns light information into blood pressure values. Now, anyone with a smartphone can have the convenience of a connected blood pressure monitor with them anytime, anywhere.

Founded July 2017, Biospectal is headquartered in Lausanne, Switzerland, with an additional office in Silicon Valley. Biospectal’s clinically validated, patented technology was developed in collaboration with the Swiss Center for Electronics and Microtechnology and represents 10+ years of non-invasive optical biosensing R&D. Read our news, follow us on LinkedIn, like us on Facebook, follow us on Twitter, or learn more at https://biospectal.com.

About Fast Company

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Stephanie Mehta. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

All trademarks used herein are the property of their respective owners.

###

Share article on social media or email:

“The Orthophos S 3D is an incredible tool that helps minimize the cost of dental treatment, reduces treatment time and enhances the end results of dental implant surgery,” says Dr. Scott A. Babin

EDMONDS, Wash. (PRWEB)
November 19, 2021

The skilled professionals at Scott A. Babin, DDS and Associates deliver a wide range of services for the entire family, keeping smiles healthy and looking beautiful, with general, restorative, cosmetic and sedation dentistry. They strive to provide the very best in advanced, cutting-edge technology for safe, highly-efficient oral health care. The practice now offers patients the advanced DentsplySirona’s Orthophos S 3D imaging system to help accurately plan dental implant treatment and other oral surgery procedures. With the advanced 3D Orthophos S system, the dentists at this clinic can now utilize a clear, detailed view of each patient’s mouth and skull bone structure, bone density, tissues and nerves to enhance the already high standard of dental care they provide.

Dental implants are the most advanced replacement for missing teeth but have historically proven to be inconvenient with trips to different specialty clinics. With the Orthophos S, 3D imaging can be completed in our office in minutes, streamlining the implant process. Cone beam technology is at the heart of the Orthophos S and takes hundreds of pictures that are used to compile an exact 3D image of the inner mechanisms of the face and jaw. Dentists are able to zoom in on specific areas and view them from alternate angles. There are numerous benefits that the Orthophos S 3D system provides, including assessing the quality of the jawbone where the implant will be placed, determining where nerves are located, measuring the density of the jawbone, pinpointing the most effective placement for implants, planning of the complete surgical procedure in advance, precisely deciding on the appropriate size and type of implants and giving the view of the exact orientation and position of each tooth.

“The Orthophos S 3D is an incredible tool that helps minimize the cost of dental treatment, reduces treatment time and enhances the end results of dental implant surgery,” says Dr. Scott A. Babin

More about Scott A. Babin, DDS and Associates:

Scott A. Babin, DDS and Associates offers a wide selection of advanced dental care services in a relaxed and family-friendly environment. Their offices in Edmonds and Renton are equipped with innovative dental technology to provide the best dental care for patients. They can handle all types of preventive and routine dental care needs, as well as specialized treatments. The highly-skilled dentists and staff at this practice provide a wide range of options under one roof, including dental cleanings, porcelain veneers, implants, teeth whitening and advanced procedures.

To find out more about the services offered at Scott A. Babin, DDS and Associates, please call (425)-775-1766 for the Edmonds location or (425)-227-7788 for the Renton clinic. Visit the website http://www.scottbabindds.com for more information or to schedule an appointment.

Share article on social media or email:

Well Screen Mobile

This opens the door for screening remote healthcare staff, as the mobile application doesn’t require scanning badges at a physical station

EUDORA, Kan. (PRWEB)
November 19, 2021

Well Screen Mobile makes it possible for healthcare organizations of all sizes to manage and screen those who enter their facilities prior to their arrival, and also those who work remotely; offering convenience and efficiency.

Stop Disease Spread with Well Screen Mobile

When healthcare facilities protect people entering their buildings, they also improve their quality of care and patient experience. Having a process for entrance management and symptom screening is the new normal, but there is no doubt that with staff shortages and fatigued employees, improved screening processes will lead to better care and greater employee satisfaction. With Well Screen mobile, employees and providers can skip the check-in line at the door, resulting in much-needed operational efficiencies and saved time without sacrificing safety.

How It Works

Staff will be asked a few questions on Well Screen’s mobile app, and the answers will be recorded and visible. Questions are intuitive and can be customized to the organization’s needs. For example, if someone answers YES to having been fully vaccinated for more than 14 days, that question will not be repeated. Well Screen mobile also:

• 
  Records temperature and symptom attestations
• Verifies vaccination status
• Sends real-time alerts for employees who are flagged
• Gives access to dashboards with detailed data on who entered the facility
• Provides facilities with options for sharing with surveyors if needed

Extend Screening Beyond the Entrance Door

Not all healthcare facilities require a physical check-in at a location and remote workers still need to screen. Well Screen mobile makes it possible to record, track and check employees in those environments, such as home health, hospice, offsite clinics, etc.

“This opens the door for screening remote healthcare staff, as the mobile application doesn’t require scanning badges at a physical station,” says Don Death, Well Screen CEO.

About Readiness Rounds, Creator of Well Screen

Founded in 2008, Readiness Rounds provides a high-reliability performance improvement solution for hospitals and healthcare systems that improves patient safety, quality of care and patient experience. The company leveraged its existing technology in response to COVID-19, with Well Screen™ Comprehensive Entrance Protocol System that screens for disease upon entrance, eliminating touchpoints that allow viruses to spread and replacing them with processes that work better and faster. Well Screen™ integrates touchless temperature scans, question-based wellness screening, employee badge scanning, visitor and vendor management, PPE supply management, vaccination verification, and is now available in mobile application format. Visit https://www.wellscreenus.com for more information.

Share article on social media or email: